Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Topical Formulation for Raynaud’s Phenomenon - Happi
Patents

Topical Formulation for Raynaud’s Phenomenon

This patented composition contains nitroglycerin, oleic acid, alpha hydroxy acid and an emollient.

Raynaud's syndrome phenomena in adult hand.

US Patent No.12,070,440 B2 (Edward T. Kisak, John M. Newsam, R. Dominic King-Smith); Permeautus, Inc., Del Mar, CA, has patented a pharmaceutically-acceptable topical composition for treating conditions such as Raynaud’s phenomenon in which peripheral blood flow in a subject is compromised.

The composition is comprised at least 4% weight by weight of nitroglycerin, at least 8% oleic acid, 1.425-1.575% of an emollient comprising a fatty acid ester of an alpha hydroxy acid, 2.85 -3.15% of hydroxypropyl cellulose, and at least 63% by weight of propylene glycol. The  composition is free of both water and hydrocarbon. The nitroglycerin is homogeneously distributed throughout the composition.

Raynaud phenomenon is a common condition, occurring in 3-5% of adults worldwide. It is more common in females than males.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters